After a year of decline in 2022, completed clinical trials were on the upswing again in 2023. According to Trialtrove, 4,295 industry-sponsored Phase I-Phase III/IV clinical trials either reached completed status or reported primary endpoints during 2023. This is a 10.7% increase over 2022.
Related resources